ISC105-R3 3 ml ready-to-use (RTU)
ISC105-R7 7 ml ready-to-use (RTU)
ISC105-C1 1 ml concentrated
As one of the cyclin-dependent kinase inhibitors that inhibit cyclin-dependent kinases 4 and 6, p16INK4A is encoded by the tumor suppressor gene CDKN2A. The tumor suppressor p16INK4A plays an important role in cell cycle regulation. Mutations in the p16 gene associated with loss or over expression of the protein are associated with increased risk of a wide range of cancers and cancer precursor lesions. The immunohistochemical identification of p16 is particularly relevant in uterine cervical lesions. Development of dysplasia is closely related to human papilloma virus (HPV) infection.
The stated primary antibody is suitable for immunohistochemical staining of FFPE tissue sections based on specific antigen-antibody reaction. Using a detection system linked to HRP or alkaline phosphatase the antigen visualization is performed via specific binding of the primary antibody. Secondary antibody is binding to the primary antibody, and the enzyme complex labels this complex. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. Each step is incubated for a precise time and temperature and requires interposed washing steps. The specimen may then be counterstained. Results are interpreted using a light microscope.
The immunostaining procedure causes a colored reaction product to precipitate at the antigen sites localized by the primary antibody.
Cellular localization: Cell nucleus/Cytoplasm.
A qualified pathologist experienced in immunohistochemistry procedures must evaluate positive and negative tissue controls before interpreting patient specimens.
Positive staining intensity should be assessed within the context of any background staining of the negative reagent control.
Note: A negative result means that the antigen in question was not detected, but not that the antigen is not present in the cells/tissues tested. An antibody panel may be used to support the results in some circumstances. Additionally, the morphology of each tissue sample should be examined utilizing a hematoxylin and eosin stained section. A qualified pathologist must interpret the patient’s morphologic findings and pertinent clinical data
See MSDS.
The following materials may be required for staining but are not provided with the primary antibody.
– Positive and negative controls
– Microscope slides (positively charged) and cover slips
– Water bath
– Humidified chamber
– Staining jars
– Stopwatch
– Xylene or xylene substitute
– Ethanol
– Deionized or distilled water
– Antigen retrieval reagent, e.g. Antigen Enhancer (HIER buffer), Cat. No. D004-500
– Detection system, e.g. IHC Complete Detection system (Goat anti mouse/rabbit HRP, DAB staining), Cat. No. D001-15
– Wash buffer: e.g. IHC Wash Buffer, Cat. No. D003-500
– Tap water/bluing reagent (e.g. ammonia water)
– Light microscope
The following materials may be required for staining but are not provided with the primary antibody.
– Positive and negative controls
– Microscope slides (positively charged) and cover slips
– Water bath
– Humidified chamber
– Staining jars
– Stopwatch
– Xylene or xylene substitute
– Ethanol
– Deionized or distilled water
– Antigen retrieval reagent, e.g. Antigen Enhancer (HIER buffer), Cat. No. D004-500
– Detection system, e.g. IHC Complete Detection system (Goat anti mouse/rabbit HRP, DAB staining), Cat. No. D001-15
– Wash buffer: e.g. IHC Wash Buffer, Cat. No. D003-500
– Tap water/bluing reagent (e.g. ammonia water)
– Light microscope
Store at 2 – 8 °C.
When stored correctly antibody is stable to the expiration date indicated on the vial. Do not use after expiration date.
To ensure proper reagent delivery and stability of the antibody, replace the dispenser cap after every use and immediately place the bottle cool in an upright position.
[1] Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008; 40: 335–44
[2] Sano T, Oyama T, Kashiwabara K et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741–8.
2024-06-10
Change(s) made: –